ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells

J Biol Chem. 2002 Jan 4;277(1):218-24. doi: 10.1074/jbc.M108476200. Epub 2001 Oct 26.

Abstract

In acute promyelocytic leukemia (APL) cells harboring the promyelocytic leukemia retinoic acid receptor alpha (PML-RARalpha) chimeric protein, retinoic acid (RA)-induced differentiation is triggered through a PML-RARalpha signaling resulting in activation of critical target genes. Induced differentiation of APL cells is always preceded by withdrawal from the cell cycle and commitment events leading to terminal differentiation. Here we have identified the human ankyrin repeat-containing protein with a suppressor of cytokine signaling box-2 (ASB-2) cDNA, as a novel RA-induced gene in APL cells. PML-RARalpha strongly enhanced RA-induced ASB-2 mRNA expression. In myeloid leukemia cells, ASB-2 expression induced growth inhibition and chromatin condensation recapitulating early events critical to RA-induced differentiation of APL cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adaptor Proteins, Signal Transducing*
  • Amino Acid Sequence
  • Base Sequence
  • Carrier Proteins / genetics
  • Carrier Proteins / physiology*
  • Cell Differentiation / drug effects
  • Chromatin / metabolism
  • Humans
  • Leukemia, Promyelocytic, Acute / pathology*
  • Molecular Sequence Data
  • Neoplasm Proteins / physiology
  • Oncogene Proteins, Fusion / physiology
  • RNA, Messenger / analysis
  • Suppressor of Cytokine Signaling Proteins
  • Tretinoin / pharmacology

Substances

  • ASB2 protein, human
  • Adaptor Proteins, Signal Transducing
  • Carrier Proteins
  • Chromatin
  • Neoplasm Proteins
  • Oncogene Proteins, Fusion
  • RNA, Messenger
  • Suppressor of Cytokine Signaling Proteins
  • promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
  • Tretinoin

Associated data

  • GENBANK/AJ251238